Illumina stock heads into the open after a 6.8% jump
Published on 09/16/2026 at 08:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Illumina stock closed at USD 222.29 on the Nasdaq on September 15, 2026, gaining 6.8% compared with the prior session. That move put the shares among the stronger performers in large-cap US names and outpaced the broader Nasdaq Composite, which slipped modestly over the same session.
September 15, 2026 in numbers
Illumina Inc. (ISIN US4523271090, Nasdaq: ILMN) saw its shares reach USD 222.29 at the Nasdaq close on September 15, 2026, up 6.8% for the day, after previously closing at USD 208.21. Per Nasdaq data reported by MarketBeat, the stock traded as high as USD 216.23 during the session before settling above that intraday peak, underscoring strong late buying interest.MarketBeat A separate market wrap placed Illumina among the leading risers in the Nasdaq 100, listing a close of USD 222.29 and a 8.28% gain for the session, highlighting the stock's role in a rebound among growth names.Sharecast A Chinese market summary likewise ranked Illumina among the top US gainers, citing a 6.76% rise to USD 222.29, consistent with the Nasdaq close.Sohu
Sector context supported the move. Illumina was described as surging alongside a coordinated upswing in diagnostics and research peers, with names such as Thermo Fisher and West Pharmaceutical also advancing in the same session, pointing to a broad rally across related healthcare technology stocks.Alphastreet Another commentary noted that the latest strength in Illumina appeared to build on still-positive sentiment following the company’s recent second-quarter results and an upgraded 2026 outlook, even though no fresh earnings release was issued on September 15, 2026.Quiver Quantitative Taken together, the session left Illumina trading above the USD 220 mark and markedly ahead of the same-day path of the major US equity indices.
Today’s drivers and data to watch
As trading approaches the US open on September 16, 2026, Illumina enters the session with momentum from the previous day’s sector-supported advance and its position near recent highs. Commentators have tied part of the support behind the stock to the company’s earlier decision to raise its 2026 outlook following strong second-quarter results, a backdrop that keeps earnings expectations in focus for upcoming quarters.Quiver Quantitative Market-wide, US indices faced pressure from higher bond yields and energy costs in recent sessions, according to broad market coverage, factors that remain relevant for growth-oriented healthcare and technology names like Illumina as investors reassess valuation and risk appetite.TheStreet No specific company event for Illumina is scheduled for today in the available coverage, but sector moves, bond yields and upcoming macro data are poised to influence trading conditions as the stock heads into today’s session.
